1,295 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
NVS Novartis AG $85.13 $197.65B N/A
Article Searches
Novartis Announces Positive Long-Term Data on Migraine Drug http://www.zacks.com/stock/news/509529/novartis-announces-positive-long-term-data-on-migraine-drug?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-509529 Sep 09, 2019 - Novartis' (NVS) migraine drug Aimovig is effective and safe in treating patients with episodic migraine in a long-term study.
FDA Grants Priority Review to Global Blood's SCD Candidate http://www.zacks.com/stock/news/505290/fda-grants-priority-review-to-global-bloods-scd-candidate?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-505290 Sep 06, 2019 - The FDA accepts Global Blood's (GBT) new drug application for voxelotor under priority review to treat sickle cell disease. A decision is expected on Feb 26, 2020.
Pharma Stock Roundup: AGN's Opioid Settlement, Line Extension Nod in EU for MRK, JNJ Drugs http://www.zacks.com/stock/news/505264/pharma-stock-roundup-agns-opioid-settlement-line-extension-nod-in-eu-for-mrk-jnj-drugs?cid=CS-ZC-FT-analyst_blog|stock_roundup-505264 Sep 06, 2019 - Allergan (AGN) settles with two Ohio plaintiffs for $5 million. Merck's (MRK) Keytruda, Roche's (RHHBY) Tecentriq and J&J's (JNJ) Stelara get EU approval for expanded use.
AstraZeneca's Tagrisso Gets Nod in China for First-Line NSCLC http://www.zacks.com/stock/news/503575/astrazenecas-tagrisso-gets-nod-in-china-for-first-line-nsclc?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-503575 Sep 05, 2019 - AstraZeneca's (AZN) Tagrisso gets a marketing approval in China for the first-line treatment of advanced or metastatic non-small cell lung cancer in patients with tumors having EGFR mutations.
Elastic Nv (ESTC) CEO and Chairman Shay Banon Sold $820,000 of Shares http://www.gurufocus.com/news/941121/elastic-nv-estc-ceo-and-chairman-shay-banon-sold-820000-of-shares Sep 04, 2019 - Elastic Nv (ESTC) CEO and Chairman Shay Banon Sold $820,000 of Shares, Stocks: ESTC, release date:Sep 04, 2019
Novartis Inks Commercialization Deal for Tysabri Biosimilar http://www.zacks.com/stock/news/501408/novartis-inks-commercialization-deal-for-tysabri-biosimilar?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-501408 Sep 04, 2019 - Novartis' (NVS) generics unit, Sandoz, inks deal with Polpharma Biologics for a proposed natalizumab biosimilar for the treatment of RRMS.
Global Blood Focuses on Lead Candidate Amid Competition http://www.zacks.com/stock/news/499644/global-blood-focuses-on-lead-candidate-amid-competition?cid=CS-ZC-FT-analyst_blog|zer_report_update-499644 Sep 03, 2019 - Global Blood (GBT) focuses on the development of its lead product candidate, voxelotor - an oral, once-daily treatment for SCD.
Pharma Stock Roundup: JNJ's Opioid Lawsuit, Regulatory Nod for LLY, BMY, RHHBY Drugs http://www.zacks.com/stock/news/495944/pharma-stock-roundup-jnjs-opioid-lawsuit-regulatory-nod-for-lly-bmy-rhhby-drugs?cid=CS-ZC-FT-analyst_blog|stock_roundup-495944 Aug 30, 2019 - Oklahoma imposes fine of $572 million on J&J (JNJ). FDA gives nod to Lilly's (LLY) Taltz while EU approves Bristol-Myers' (BMY) Empliciti and Roche's (RHHBY) Tecentriq for expanded patient population.
NVS or NVO: Which Is the Better Value Stock Right Now? http://www.zacks.com/stock/news/431571/nvs-or-nvo-which-is-the-better-value-stock-right-now?cid=CS-ZC-FT-431571 Jun 19, 2019 - NVS vs. NVO: Which Stock Is the Better Value Option?
Jazz's (JAZZ) New Sleep Drug Sunosi Gets Schedule IV Status http://www.zacks.com/stock/news/431105/jazzs-jazz-new-sleep-drug-sunosi-gets-schedule-iv-status?cid=CS-ZC-FT-431105 Jun 18, 2019 - Jazz Pharmaceuticals' (JAZZ) recently approved sleep drug, Sunosi, receives schedule IV designation under controlled substance list from the Drug Enforcement Agency.

Pages: 1234567...130

<Page 2>